Lymphocyte immunotherapy (LI) increases serum levels of progesterone induced blocking factor (PIBF)

American Journal of Reproductive Immunology

Volumn 37, Issue 1, 1997, Pages 17-20

  Check, Jerome H ^a,b   Arwitz, Maria ^a   Gross, Jenifer ^a   Peymer, Mark ^a   Szekeres Bartho, Julia ^b  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b NONE

Author keywords

Immunomodulatory protein; IVF; Leukocyte immunization; NK cells; Progesterone receptor; Spontaneous abortion

Indexed keywords

CD8 ANTIGEN; POLYCLONAL ANTIBODY; PROGESTERONE BINDING PROTEIN;

ARTICLE; CLINICAL ARTICLE; CONCEPTION; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOCYTOCHEMISTRY; IMMUNOMODULATION; IMMUNOTHERAPY; INFERTILITY; PREGNANCY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; SPONTANEOUS ABORTION; T LYMPHOCYTE;

EID: 0031038515     PISSN: 87558920     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0897.1997.tb00188.x     Document Type: Article

References (23)

1. Check JH. The role of progesterone in supporting implantation and preventing early pregnancy loss. In Implantation and Early Pregnancy in Humans. Barnea ER, Check JH, Gedis Grudzinskas J, Maruo T (eds). Parthenon Publishing Group. 1994, chap. 11, pp 137-160.
2. Stites DP, Siiteri PK. Steroids as immunosuppressants in pregnancy. Immunol Rev 1983; 75:117-138.
3. Szekeres-Bartho J, Csernus V, Hadnagy J. The blocking effect of progesterone on lymphocyte responsiveness is receptor-mediated. Biol Immunol Reprod 1989; 15:36.
4. Szekeres-Bartho J, Szekeres GY, Debre P, Autran B, Chaouat G. Reactivity of lymphocytes to a progesterone receptor-specific monoclonal antibody. Cell Immunol 1990; 125:273-283.
5. Roussev RG, Higgins NG, McIntyre JA. Phenotypic characterization of normal human placental mononuclear cells. J Reprod Immunol 1993; 25:15-30.
6. Paldi A, d'Auriol L, Misrahi M, Bakos AM, Chaouat G, Szekeres-Bartho J. Expression of the gene coding for the progesterone receptor in activated human lymphocytes. Endoc J 1994; 2:317-319.
7. Szekeres-Bartho J, Kilar F, Falkay G, Csernus V, Torok A, Pacsa AS. Progesterone-treated lymphocytes of healthy pregnant women release a factor inhibiting cytotoxicity and prostaglandin synthesis. Am J Reprod Immunol Microbiol 1985; 9:15-18.
8. Szekeres-Bartho J, Autran B, Debre P, Andreu G, Denver L, Chaouat G. Immunoregulatory effects of a suppressor factor from healthy pregnant women's lymphocytes after progesterone induction. Cell Immunol 1989; 122:281-294.
9. De Fougerolles R, Baines M. Modulation of natural killer activity influences resorption rates in CBA×DBA/2 matings. J Reprod Immunol 1987; 11:147-153.
10. Wegmann TG, Hui Lin, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: Is successful pregnancy a Th2 phenomenon? Immunology Today 1993; 14:353-356.
11. Mosmann TR, Coffman RL. Heterogeneity of eytokine secretion patterns and functions of helper T cells. Adv Immunol 1989; 46:111-147.
12. Lin H, Mosmann TR, Guilbert L, Tuntipopiat S, Wegmann TG. Synthesis of helper 2-type cytokines at the maternal-fetal interface. J Immunol 1993; 151:4562-4573.
13. Szekeres-Bartho J, Faust ZS, Varga P, Szereday L, Kelemen K. The immunological pregnancy protective effect of progesterone is manifested via controlling cytokine production. Am J Reprod Immunol 1996; 35:348-351.
14. Szekeres-Bartho J, Weill BJ, Mike G, Houssin D, Chaouat G. Progesterone receptors in lymphocytes of liver-transplanted and transfused patients. Immunology Letters 1989; 22:259-261.
15. Check JH, Kaplan N, Nazari A, Peynier M, Chuong J. Pregnancy and spontaneous abortion (SAB) rates following lymphocyte immunotherapy (LI) in patients undergoing in vitro fertilization-embryo transfer (IVF-ET). Abstracts of the 16th Annual Meeting of the American Society for Reproductive Immunology 1996; pp 457-158 (abs. #P204).
16. Szekeres-Bartho J, Faust ZS, Varga P. The expression of a progesterone induced immunomodulatory protein in pregnancy lymphocytes. Am J Reprod Immunol 1995; 34:342-348.
17. Check JH, Szekeres-Bartho J, O'Shaughnessy A. Progesterone induced blocking factor seen in pregnancy lymphocytes soon after implantation. Am J Reprod Immunol 1996; 35:277-280.
18. Check JH, Arwitz M, Gross J, Szekeres-Bartho J, Wu CH. Detection of progesterone induced blocking factor (PIBF) in very early pregnancy correlates more with successful implantation then more conception. Abstracts of the 43rd Annual Meeting of the Society for Gynecologic Investigation 1996; p 201A (abs. #93).
19. Arwitz, M, Gross J, Check JH, Szekeres-Bartho J. The association of progesterone induced blocking factor (PIBF) and first trimester spontaneous abortion (SAB). Abstracts of the 44th Annual Meeting of the Pacific Coast Fertility Society 1996; p A6 (abs. # O-11).
20. Carp HJA, Toder V, Mashiach S, Rabinovici J. Effect of paternal leukocyte immunization on implantation after biochemical pregnancies and repeated failure of embryo transfer. Am J Reprod Immunol 1994; 31:112-115.
21. Nichols TC, Kang JA, Angkachatchi V, Beer AE, Beaman KD. Expression of a membrane form of the pregnancy associated protein TJ6 on lymphocytes. Cell Immunol 1994; 155:219-229.
22. Coulam CB, Beaman KD. Reciprocal alteration in circulating TJ64+ CD19+ and TJ64+ leukocytes in early pregnancy predicts success or miscarriage. Am J Reprod Immunol 1995; 34:219-224.
23. Coulam CB, Stephenson M, Stern JJ, Clark DA. Immunotherapy for recurrent pregnancy loss: Analysis of results from clinical trials. Am J Reprod Immunol 1996; 35:352-359.